Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)
Others
Ratios

NRX Pharmaceuticals (NRXP) Other Operating Expenses (2024 - 2025)

NRX Pharmaceuticals (NRXP) has disclosed Other Operating Expenses for 2 consecutive years, with $778000.0 as the latest value for Q4 2025.

  • Quarterly Other Operating Expenses rose 109.22% to $778000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$4.9 million through Dec 2025, up 53.36% year-over-year, with the annual reading at -$28.1 million for FY2025, 13.22% down from the prior year.
  • Other Operating Expenses for Q4 2025 was $778000.0 at NRX Pharmaceuticals, up from -$5.7 million in the prior quarter.
  • The five-year high for Other Operating Expenses was $778000.0 in Q4 2025, with the low at -$8.4 million in Q4 2024.